CLINICAL_TRIALS
trial_result
· 2024-12-13
Clinical Trial Update: A Microdose Evaluation Study of ABY-029 in Recurrent Glioma [EARLY_Phase 1]
Summary
A microdose Phase 1 study evaluating ABY-029 in recurrent glioma has completed, with results posted on 2024-12-13.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Glioma | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-12-13